The general aims of the EyeOME are: 
(i) to develop tools for the identification and quantification of proteins in the human eye, and to apply these tools to identify disease pathways that will lead to new therapeutic interventions and biomarkers for the prevention and treatment of blinding eye diseases; 
(ii) to build a network and community of scientists who will work together and facilitate common interests in the application of proteomics to eye diseases; 
(iii) to characterize the proteome of the normal human eye during the entire life cycle, including protein variants and PTMs; 
(iv) to establish standard operating procedures for study of the human eye proteome, such as the processing, dissection, and storage of eye bank eyes, collection of tears, aqueous humor, and vitreous, collection of ocular tissues during surgery, and storage of samples; 
(v) to establish standards for the reporting of proteomic data in order to develop a high-confidence human eye proteome database; 
(vi) to establish repositories of human samples to facilitate exchange and collaboration; 
(vii) to collect eye proteomedata and research protocols from members for open access; 
(viii) to raise funds for exchange of postdoctoral fellows, symposia at HUPO, and collaborative symposia with the Association for Research in Vision and Ophthalmology (ARVO). A comprehensive proteomics analysis of the human iris tissue: ready to embrace postgenomics precision medicine in ophthalmology.